Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC)

被引：1
|
作者：
Hansen, O. [1 ]
Knap, M. [2 ]
Khalil, A. [2 ]
Nyhus, C. [3 ]
Brink, C. [4 ]
Hoffmann, L. [5 ]
Schytte, T. [1 ]
机构：
[1] Odense Univ Hosp, Oncol, Odense, Denmark
[2] Aarhus Univ Hosp, Oncol, Aarhus, Denmark
[3] Vejle Hosp, Oncol, Vejle, Denmark
[4] Odense Univ Hosp, Lab Radiat Phys, Odense, Denmark
[5] Aarhus Univ Hosp, Med Phys, Aarhus, Denmark
来源：
RADIOTHERAPY AND ONCOLOGY | 2017年 / 123卷
关键词：
D O I：
10.1016/S0167-8140(17)31664-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1229
引用
收藏
页码：S663 / S663
页数：1
相关论文
共 50 条
  • [31] Phase II Trial: Concurrent Chemotherapy and Radiation Therapy With Nitroglycerin in Locally Advanced Non-small Cell Lung Cancer Patients
    Blake, M.
    De la Mata, D.
    Zamora, J.
    Pena, O.
    Macedo, O.
    Flores Estrada, D.
    Turcott, J.
    Arrieta, O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S574 - S574
  • [32] OUTCOMES OF RADIOTHERAPY ALONE FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC) IN PATIENTS UNFIT FOR CHEMO-RADIOTHERAPY
    Gouran-Savadkoohi, Mohammad
    Pond, Greg
    Quan, Kimmen
    Mesci, Aruz
    Swaminath, Anand
    Okawara, Gordon
    Ribeiro, Derek
    Chow, Tom
    Wright, James
    Tsakiridis, Theos
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S39 - S39
  • [33] Black Patients With Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)-An Inclusive Multi-Modality Approach Is Justified
    Melissa, Vyfhuis
    Bhooshan, Neha
    Molitoris, Jason
    Edelman, Martin
    Burrows, Whitney
    Nichols, Elizabeth
    Suntharalingam, Mohan
    Donahue, James
    Shamus, Carr
    Friedberg, Joseph
    Badiyan, Shahed
    Feliciano, Josephine
    Feigenberg, Steven
    Mohindra, Pranshu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E37 - E37
  • [34] A phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC).
    Hoffman, PC
    Mauer, AM
    Haraf, DC
    Lester, EP
    Szeto, LL
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 648S - 648S
  • [35] A multicenter phase II study of sorafenib in combination with erlotinib patients with advanced non-small cell lung cancer (NSCLC)
    Cho, B.
    Kim, S.
    Heo, D. S.
    Kang, S.
    Kim, H.
    Lee, D.
    Kim, D.
    Jung, M.
    Choi, J.
    Kim, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] A randomized phase II trial of concurrent chemoradiation of oral vinorelbine and two doses of radiotherapy, 60 and 66 Gy, in local-regionally advanced non-small cell lung cancer (LA-NSCLC).
    Hansen, Olfred
    Knap, Marianne
    Khalil, Azza
    Nyhus, Christa Haugaard
    McCulloch, Tine
    Holm, Bente
    Brink, Carsten
    Hoffmann, Lone
    Schytte, Tine
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer
    Halmos, Balazs
    Pennell, Nathan A.
    Fu, Pingfu
    Saad, Shumaila
    Gadgeel, Shirish
    Otterson, Gregory A.
    Mekhail, Tarek
    Snell, Michael
    Kuebler, Philip
    Sharma, Neelesh
    Dowlati, Afshin
    ONCOLOGIST, 2015, 20 (11): : 1298 - 1303
  • [38] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Phase II trial of second-line erlotinib and digoxin in patients with non-small cell lung cancer (NSCLC)
    Kayali, F.
    Janjua, M. A.
    Laber, D. A.
    Miller, D. M.
    Day, J. M.
    Kloecker, G. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] Metformin Use during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
    Wink, Krista
    Belderbos, Jose
    Dieleman, Edith
    Rossi, Maddalena
    Rasch, Coen
    Damhuis, Ronald
    Houben, Ruud
    Troost, Esther
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S278 - S279
12345